Create an account to read this article
You need to create an account to read this article.
Create Account Sign in
Urology
Nephrology
Laboratory Medicine
Diabetes and Endocrinology
Cardiology and CTVS
Canagliflozin Reduces Hyperkalemia Risk In Patients With Diabetes And CKD: CREDENCE Trial
0 Comments
Post a comment
No comments yet. Be the first to comment!